Literature DB >> 21569791

Rates and correlates of influenza vaccination among HIV-infected adults in the HIV Outpatient Study (HOPS), USA, 1999-2008.

Marcus D Durham1, Kate Buchacz, Carl Armon, Pragna Patel, Kathy Wood, John T Brooks.   

Abstract

BACKGROUND: We sought to describe rates of vaccination among HIV-infected adults in care and identify factors associated with vaccination.
METHODS: Using data abstracted from medical records of participants in the HIV Outpatient Study (HOPS) during 8 influenza seasons (1999-2008) and negative binomial models with generalized estimating equation methods, we examined factors associated with increased prevalence of annual influenza vaccination.
RESULTS: Among active patients, 25.8% to 43.3% were vaccinated for influenza each year (annual mean=35%, test for trend p=0.71). Vaccination rates peaked in October and November of each season and decreased sharply thereafter. In multivariable analysis, patients who were male (67.2%), non-Hispanic white (70%) or Hispanic (66%), had lower HIV viral loads (73.5%), were prescribed antiretroviral treatment (72.7%), or had a greater number of clinical encounters per year (86.7%) were more likely to receive influenza vaccination. DISCUSSION: The decreased likelihood of vaccination among women and non-Hispanic black patients suggests the need for focused efforts to reduce disparities. Increasing patient and clinician education on the importance of universal vaccination, and ensuring that vaccination activities continue in HIV clinics during the later months of the influenza season may improve influenza vaccine coverage. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21569791     DOI: 10.1016/j.ypmed.2011.04.015

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  6 in total

1.  Sometimes, more is better.

Authors:  Edgar Turner Overton
Journal:  J Infect Dis       Date:  2012-01-24       Impact factor: 5.226

Review 2.  An immunization update for HIV-infected adults in the United States: review of the literature.

Authors:  Patricia A Cioe; Kathleen Melbourne; Jerome Larkin
Journal:  J Assoc Nurses AIDS Care       Date:  2015 Mar-Apr       Impact factor: 1.354

3.  Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project.

Authors:  Rulin C Hechter; Lei Qian; Sara Y Tartof; Lina S Sy; Nicola P Klein; Eric Weintraub; Cheryl Mercado; Allison Naleway; Huong Q McLean; Steven J Jacobsen
Journal:  Vaccine       Date:  2019-05-04       Impact factor: 3.641

4.  Assessing influenza vaccination coverage and predictors in persons living with HIV/AIDS in Louisiana, June 2002-June 2013.

Authors:  Patrick Maloney; Ariane Rung; Stephanie Broyles; John Couk; Edward Peters; Susanne Straif-Bourgeois
Journal:  J Prev Med Hyg       Date:  2022-04-26

5.  Vaccine uptake and barriers to vaccination among at-risk adult populations in the US.

Authors:  Irina Kolobova; Mawuli Kwame Nyaku; Anna Karakusevic; Daisy Bridge; Iain Fotheringham; Megan O'Brien
Journal:  Hum Vaccin Immunother       Date:  2022-05-10       Impact factor: 4.526

6.  System factors to explain 2009 pandemic H1N1 state vaccination rates for children and high-risk adults in US emergency response to pandemic.

Authors:  Carlo Davila-Payan; Julie Swann; Pascale M Wortley
Journal:  Vaccine       Date:  2013-11-25       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.